The core activity of Isanas AG is the development of new therapies for severe inflammatory diseases, such as multiple sclerosis, arthritis, asthma and others.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Development of novel therapies for inflammatory diseases
Development of novel therapies for severe inflammatory diseases such as multiple sclerosis; identification of new active ingredients, investigation of known active ingredients, and further development of selected substances up to use in patients.
Multiple Sclerosis programme
Programme «Multiple Sclerosis on Vacation» / «Multiple Sklerose macht Ferien», which, according to the website, is set to start soon; interested parties are asked to get in touch.
Knowledge
No knowledge articles yet
Once Isanas AG has claimed this profile, we'll publish editorial articles and case studies here together.